Anaxomics Biotech Sl Blog Applying Anaxomics's TPMS to improve clinical trial results (4) - Sample size reduction: Homogenizing the population by means of mechanistic-based exclusion criteria

Clinical trials are the most expensive part of the drug development process, mostly due to the large number of subjects that are required to reach statistical significance. Discover with us how Anaxomics solves this problem through clinical trial sample size reduction.